Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E

References

• Cali AM, Capio S. Obesity in children and adolescents. J Clin Endocrinol Metab 2008;93:31–36.
   PubMed Web of Science ®Google Scholar
• Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010;362: 485–493.
   PubMed Web of Science ®Google Scholar
• Mohn A, Catino M, Capanna R, Giannini C, Marcovecchio M, Chiarelli F. Increased oxidative stress in prepubertal severely obese children: effect of a dietary restriction-weight loss program. J Clin Endocrinol Metab 2005;90:2653–2658.
   PubMed Web of Science ®Google Scholar
• Giannini C, de Giorgis T, Scarinci A, Cataldo I, Marcovecchio ML, Chiarelli F, Mohn A. Increased carotid intima-media thickness in pre-pubertal children with constitutional leanness and severe obesity: the speculative role of insulin sensitivity, oxidant status, and chronic inflammation. Eur J Endocrinol 2009;161:73–80.
   PubMed Web of Science ®Google Scholar
• Otani H. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 2011;15:1911–1926.
   PubMed Web of Science ®Google Scholar
• Barshop NJ, Francis CS, Schwimmer JB, Lavine JE. Nonalcoholic fatty liver disease as a comorbidity of childhood obesity. Ped Health 2009;3:271–281.
   PubMedGoogle Scholar
• Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004;114:147–152.
   PubMed Web of Science ®Google Scholar
• Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology 2009; 50:1282–1293.
   PubMed Web of Science ®Google Scholar
• Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010;7:195–203.
   PubMed Web of Science ®Google Scholar
• Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118:1388–1393.
   PubMed Web of Science ®Google Scholar
• Tiniakos DG, Vos BM, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Patholo Mech Dis 2010;5:145–171.
   PubMed Web of Science ®Google Scholar
• Day CP, James OFW. Steatohepatitis: a tale of two ‘‘hits’’. Gastroenterology 1998;114:842–845.
   PubMed Web of Science ®Google Scholar
• D’Adamo E, Giannini C, Chiavaroli V, de Giorgis T, Verrotti A, Chiarelli F, Mohn A. What is the significance of soluble and endogenous secretory receptor for advanced glycation end products in liver steatosis in obese pre-pubertal children?Antioxid Redox Signal 2010;14:1167–1172.
   Google Scholar
• Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, et al.Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006;91:4287–4294.
   PubMed Web of Science ®Google Scholar
• Cali AM, De Oliveira AM, Kim H, Chen S, Reyes-Mugica M, Escalera S, et al.Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?Hepatology 2009;49: 1896–1903.
   PubMed Web of Science ®Google Scholar
• Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, et al.Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol 2010;105:2093–2102.
   PubMed Web of Science ®Google Scholar
• Alisi A, Nobili V. Non-alcoholic fatty liver disease in children now: Lifestyle changes and pharmacologic treatments. Nutrition. 2012;28:722–726.
   PubMedGoogle Scholar
• Barshop NJ, Francis CS, Schwimmer JB, Lavine JE. Nonalcoholic fatty liver disease as a comorbidity of childhood obesity. Ped Health 2009;3:271–281.
   PubMedGoogle Scholar
• Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 2012;56:255–266.
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al.Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis. N Engl J Med 2010; 362:1675–1685.
   PubMed Web of Science ®Google Scholar
• Nobili V, Manco M, Devito R, Ciampalini P, Piemonte F, Marcellini M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2006;24:1553–1561.
   PubMed Web of Science ®Google Scholar
• Akcam M, Boyaci A, Pirgon O, Kaya S, Uysal S, Dundar BN. Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver. Int J Vitam Nutr Res 2011;81:398–406.
   PubMedGoogle Scholar
• Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, et al.Effect of Vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents. The TONIC randomized controlled trial. JAMA 2011;305:1659–1668.
   PubMed Web of Science ®Google Scholar
• D’Adamo E, Impicciatore M, Capanna R, Marcovecchio ML, Masuccio FG, Chiarelli F, Mohn A. Liver steatosis in obese prepubertal children: a possible role of insulin resistance. Obesity 2008;16:677–683.
   PubMedGoogle Scholar
• Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. Body mass index variations: centiles from birth to 87 y. Eur J Clin Nutr 1991;45:13–21.
   PubMed Web of Science ®Google Scholar
• D’Adamo E, Marcovecchio ML, Giannini C, Capanna R, Impicciatore M, Chiarelli F, Mohn A. The possible role of liver steatosis in defining metabolic syndrome in prepubertal children. Metabolism 2010;59:671–676.
   PubMedGoogle Scholar
• Tremblay AJ, Morrissette H, Gagné JM, Bergeron J, Gagnè C, Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 2004;37:785–790.
   PubMed Web of Science ®Google Scholar
• Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour S, Burgert TS, et al.Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 2004;89:1096–1110.
   PubMed Web of Science ®Google Scholar
• Roberts LJ, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28:505–513.
   PubMed Web of Science ®Google Scholar
• Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:27–38.
   PubMed Web of Science ®Google Scholar
• Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, et al.Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 2009;106:15430–15435.
   PubMed Web of Science ®Google Scholar
• Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 1997;17:2309–2315.
   PubMed Web of Science ®Google Scholar
• Giannini C, de Giorgis T, Scarinci A, Cimapani M, Marcovecchio ML, Chiarelli F, Mohn A. Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children. Atherosclerosis 2008;197:448–456.
   PubMed Web of Science ®Google Scholar
• Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, et al.Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2005;25:2587–2593.
   PubMed Web of Science ®Google Scholar
• Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009;119:628–647.
   PubMed Web of Science ®Google Scholar
• Singh U, Devaraj S, Jialal I. Vitamin E, oxidative stress and inflammation. Annu Rev Nutr 2005;25:151–174.
   PubMed Web of Science ®Google Scholar
• Kirmizis D, Chatzidimitriou D. Antiatherogenic effects of vitamin E: the search for the Holy Grail. Vasc Health Risk Manag 2009;5:767–774.
   PubMedGoogle Scholar
• D’Adamo E, Cali AMG, Weiss R, Santoro N, Pierpont B, Northrup V, Caprio S. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 2012;33:1817–1822.
   Google Scholar
• Perseghin G, Bonfanti R, Magni S, Lattuada G, De Cobelli F, Canu T, Esposito A, et al.Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 2006;291:697–703.
   PubMed Web of Science ®Google Scholar
• Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012;;3:CD007176.
   Google Scholar
• Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al.The utility of radiological imaging of nonalcoholic fatty liver disease. Gastroenterology 2006;123: 745–750.
   Google Scholar